Results 11 to 20 of about 60,066 (206)

Left Ventricular Assist Devices [PDF]

Circulation, 2018
Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage heart failure patients with >22 000 implantations to date. Though originally conceived for bridge-to-transplant indication, significant advancements in medical management as well as technology with arrivals of newer generation devices have improved patient ...
Jason J. Han, Michael A. Acker, Pavan Atluri   +2 more
openaire   +1 more source

Left Ventricular Assist Device Support Complicates the Exercise Physiology of Oxygen Transport and Uptake in Heart Failure

Cardiac Failure Review, 2019
Low-output forward flow and impaired maximal exercise oxygen uptake (VO2 max) are hallmarks of patients in advanced heart failure. The continuous-flow left ventricular assist device is a cutting-edge therapy proven to increase forward flow, yet this ...
Erik H Van Iterson
doaj   +1 more source

Left Ventricular Assist Device-Related Complications

Journal of Cardiovascular Emergencies, 2020
Left ventricular assist device (LVAD) has emerged as a safe, durable, and revolutionary therapy for end-stage heart failure patients. Despite the appearance of newer-generation devices that have improved patient outcomes, the burden of adverse events ...
Clement Alexandra, Anghel Larisa, Sascău Radu, Stătescu Cristian   +3 more
doaj   +1 more source

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Cardiogenic shock (CS) is a complex syndrome associated with high morbidity and mortality. In recent years, many US hospitals have formed multidisciplinary shock teams capable of rapid diagnosis and triage. Because of preexisting collaborative
Joseph I. Wang, Daniel Y. Lu, MHS, Dmitriy N. Feldman, Stephen A. McCullough, Parag Goyal, Maria G. Karas, Irina Sobol, Evelyn M. Horn, Luke K. Kim, Udhay Krishnan   +10 more
doaj   +1 more source

Left Ventricular Assist Device (LVAD) Implantation and Renal Dysfunction [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy, 2018
Pathophysiological, pathomorphological and functional changes in the kidneys after left ventricular assist device implantation have not yet been fully understood and represent an actual problem of our time.
Assem Nogaibayeva, Bagdat Sultanova, Myrzabek Makhmutov   +2 more
doaj   +1 more source

Understanding Left Ventricular Assist Devices

Blood Purification, 2018
<b><i>Background/Aims:</i></b> Long-term mechanical assist devices are now commonly used in the treatment of severe heart failure to unload the failing ventricle, maintain sufficient end-organ perfusion and improve functional capacity.
Aissaoui, Nadia (Dr. rer. nat.), Jouan, Jerome, Gourjault, Melissa, Diebold, Benoit (Prof. Dr.), Ortuno, Sofia, Hamdan, Amer, Latremouille, Christian (Prof. Dr. med.), Pirracchio, Romain (Prof. Dr. med.), Morshuis, Michiel (Dr. med.)   +8 more
openaire   +3 more sources

Usefulness of regional right ventricular and right atrial strain for prediction of early and late right ventricular failure following a left ventricular assist device implant: A machine learning approach [PDF]

, 2019
Background: Identifying candidates for left ventricular assist device surgery at risk of right ventricular failure remains difficult. The aim was to identify the most accurate predictors of right ventricular failure among clinical, biological, and ...
Agnese V., Bellavia D., Clemenza F., Coronnello C., di Gesaro G., Falletta C., Gorcsan S. J., Iacovoni A., Maalouf J., Novo G., Pasta S., Pilato M., Sciacca S., Senni M., Simon M.   +14 more
core   +1 more source

Left Ventricular Assist Devices [PDF]

Health Affairs, 2015
Kory Lavine, Susan Joseph
  +7 more sources

A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients [PDF]

, 2014
BACKGROUND: Thrombotic events are a common complication of left ventricular assist device placement and warrant prophylactic anticoagulation. Heparin is the most common anticoagulant used for prophylaxis of thrombotic events in left ventricular assist ...
Aesha Shah, Nicholas Tillman, Scott T Benken, Suhuir Dajani, Toby Thomas   +4 more
core   +1 more source

Experience with percutaneous right ventricular support in the early post-left ventricular assist device implantation period (clinical case report and literature reviews)

Вестник трансплантологии и искусственных органов, 2023
Implantable left ventricular assist device (LVAD) is a state-of-the-art treatment for adults and children with end-stage heart failure. The early and late period after LVAD implantation can be severely complicated.
V. N. Poptsov, E. A. Spirina, D. V. Ryabtsev, A. K. Solodovnikova, A. S. Epremian   +4 more
doaj   +1 more source